Page 62 - GlaxoSmithKline Pharmaceuticals AR 2012

58
Notes to the Financial Statements for the year ended 31st December, 2012 — continued
(iv) Details relating to persons referred to in item 1(iv) above:
Rupees in lakhs
2012 2011
1 Remuneration/commission/sitting fees .. .. .. .. 15,53.28 13,35.37
2 Payments under the long-term incentive plan .. .. .. 1,55.05 91.00
3 Interest income on loans given .. .. .. .. .. 0.74 0.93
4 Rent for residential flat .. .. .. .. .. .. — 1.14
5 Outstanding loans receivable .. .. .. .. .. 25.21 17.51
(v) Disclosure in respect of material transactions with persons referred to in item 1(iv) above:
Rupees in lakhs
2012 2011
(a) Remuneration / commission / sitting fees
Dr. H.B. Joshipura .. .. .. .. .. .. .. 3,07.04 3,13.06
Mr. M.B. Kapadia .. .. .. .. .. .. .. 1,95.53 1,92.43
Dr. A. Banerjee .. .. .. .. .. .. .. 3,03.97 1,09.55
(b) Payments under the long-term incentive plan
Dr. H.B. Joshipura .. .. .. .. .. .. .. 36.08 20.37
Mr. M.B. Kapadia .. .. .. .. .. .. .. 25.09 14.15
Dr. A. Banerjee .. .. .. .. .. .. .. 48.03 11.47
(c) Interest income on loans given
Mr. H. Buch .. .. .. .. .. .. .. .. 0.23 0.23
Mr. R. Bartaria .. .. .. .. .. .. .. 0.18 0.19
Mr. S. Khanna .. .. .. .. .. .. .. 0.12 0.17
Mr. S. Dheri .. .. .. .. .. .. .. 0.21 *
(d) Rent for residential flat
Dr. A. Banerjee .. .. .. .. .. .. .. — 1.14
(e) Outstanding loans receivable
Mr. H. Buch .. .. .. .. .. .. .. 7.60 7.73
Mr. R. Bartaria .. .. .. .. .. .. .. 6.08 6.17
Mr. S. Khanna .. .. .. .. .. .. .. 2.40 3.61
Mr. S. Dheri .. .. .. .. .. .. .. 9.13 *
* Not a related party during the previous year.
49 The foreign currency outstanding balances that have not been hedged by any derivative instrument or otherwise as at the
Balance Sheet date are as follows:
Rupees in lakhs
Particulars Pound
Sterling
United
States
Dollar
Euro Japanese
Yen
Singapore
Dollar
UAE
Dirham
Australian
Dollar
Swiss
Franc
Chinese
Yuan
Malaysian
Ringgit
Thailand
Baht
Receivables 5.25 13,77.73 6,27.68 — 0.54 0.15 — — 0.01 0.01 0.01
(1.64) (10,03.56) (4,28.85) — (1.52) (0.18) — (29.33) — — —
Payables 9,74.36 26,31.63 78.34 — — — 25.59 — — — —
(14,56.95) (47,48.71) (42.40) (2.49) — — (29.32) — — — —
(Figures in brackets pertain to the year 2011)